Characteristics | Cases* (N = 8,195) | Controls* (N = 81,950) | Odds Ratio^ | 95% Confidence Interval | ||
---|---|---|---|---|---|---|
 | N | % | N | % |  |  |
Any NSAID use | Â | Â | Â | Â | Â | Â |
Ever versus never | Â | Â | Â | Â | 1.04 | 0.99 to 1.10 |
   Never/rare1 | 5,353 | 65 | 54,742 | 67 | 1.00 |  |
   Recent use2 | 1,147 | 14 | 11,236 | 14 | 1.00 | 0.93 to 1.08 |
   Former use3 | 1,695 | 21 | 15,972 | 20 | 1.02 | 0.96 to 1.09 |
Selective Cox-2 Inhibitors | Â | Â | Â | Â | Â | Â |
Ever versus never | Â | Â | Â | Â | 1.08 | 0.99 to 1.18 |
   Never/rare1 | 6,361 | 78 | 64,549 | 79 | 1.00 |  |
   Recent use2 | 442 | 5 | 4,105 | 5 | 0.98 | 0.84 to 1.15 |
   Former use3 | 1,392 | 17 | 13,296 | 16 | 1.12 | 1.02 to 1.24 |
Non-selective Non-aspirin | Â | Â | Â | Â | Â | Â |
Non-Steroidal Anti-Inflammatory Drugs | Â | Â | Â | Â | Â | Â |
Ever versus never | Â | Â | Â | Â | 1.04 | 0.98 to 1.10 |
   Never/rare1 | 7,494 | 91 | 75,636 | 92 | 1.00 |  |
   Recent use2 | 184 | 2 | 1,812 | 2 | 1.06 | 0.95 to 1.17 |
   Former use3 | 517 | 6 | 4,502 | 6 | 1.03 | 0.97 to 1.10 |
Aspirin | Â | Â | Â | Â | Â | Â |
Ever versus never | Â | Â | Â | Â | Â | Â |
   Never/rare1 | 7,396 | 90 | 73,947 | 90 | 0.98 | 0.90 to 1.07 |
   Recent use2 | 548 | 7 | 5,596 | 7 | 0.96 | 0.87 to 1.06 |
   Former use3 | 251 | 3 | 2,407 | 3 | 1.02 | 0.89 to 1.17 |